Litcius/Paper detail

Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease

Albert Selva-O’Callaghan, Fredeswinda Romero-Bueno, Ernesto Trallero‐Araguás, Albert Gil‐Vila, Juan Carlos Ruiz‐Rodríguez, Olga Sánchez‐Pernaute, Iago Pinal‐Fernandez

2021Current Treatment Options in Rheumatology51 citationsDOIOpen Access PDF

Topics & Concepts

Interstitial lung diseaseMedicineMDA5LungDiseasePathologyInternal medicineChemistryGeneRNA interferenceRNABiochemistryInflammatory Myopathies and DermatomyositisSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease | Litcius